Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The treatment of plasma cell myeloma.

× No keyword cloud information.

8 in total

Review 1. An assessment of massive-dose chemotherapy of malignant disease.

Authors: D E Bergsagel
Journal: Can Med Assoc J Date: 1971-01-09 Impact factor: 8.262

2. Factors influencing the prognosis in myelomatosis.

Authors: A A Dawson; D Ogston
Journal: Postgrad Med J Date: 1971-10 Impact factor: 2.401

3. Management of multiple myeloma.

Authors: J S Malpas
Journal: Br Med J Date: 1969-04-19

4. Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.

Authors: Marta Chesi; Geoffrey M Matthews; Victoria M Garbitt; Stephen E Palmer; Jake Shortt; Marcus Lefebure; A Keith Stewart; Ricky W Johnstone; P Leif Bergsagel
Journal: Blood Date: 2012-03-26 Impact factor: 22.113

5. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

Authors: D E Bergsagel; D H Cowan; R Hasselback
Journal: Can Med Assoc J Date: 1972-11-04 Impact factor: 8.262

6. Peptichemio induction therapy in myelomatosis.

Authors: G Merlini; P G Gobbi; A Riccardi; G Riva; C Sardi; S Perugini
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

7. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.

Authors:
Journal: Br Med J Date: 1971-03-20

8. Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.

Authors:
Journal: Br J Cancer Date: 1980-12 Impact factor: 7.640

8 in total